These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies. Seifert SA; Boyer LV Ann Emerg Med; 2001 Feb; 37(2):189-95. PubMed ID: 11174238 [TBL] [Abstract][Full Text] [Related]
7. Cross neutralization of common Southeast Asian viperid venoms by a Thai polyvalent snake antivenom (Hemato Polyvalent Snake Antivenom). Leong PK; Tan CH; Sim SM; Fung SY; Sumana K; Sitprija V; Tan NH Acta Trop; 2014 Apr; 132():7-14. PubMed ID: 24384454 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of two common antivenoms for North, Central, and South American Micrurus envenomations. de Roodt AR; Paniagua-Solis JF; Dolab JA; Estévez-Ramiréz J; Ramos-Cerrillo B; Litwin S; Dokmetjian JC; Alagón A J Toxicol Clin Toxicol; 2004; 42(2):171-8. PubMed ID: 15214622 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation. Gutiérrez JM; León G; Lomonte B Clin Pharmacokinet; 2003; 42(8):721-41. PubMed ID: 12846594 [TBL] [Abstract][Full Text] [Related]
10. Cross-reactivity and neutralization of Indian King cobra (Ophiophagus hannah) venom by polyvalent and monovalent antivenoms. Gowtham YJ; Mahadeswaraswamy YH; Girish KS; K K Int Immunopharmacol; 2014 Jul; 21(1):148-55. PubMed ID: 24815989 [TBL] [Abstract][Full Text] [Related]
11. Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique. Guidolin FR; Caricati CP; Marcelino JR; da Silva WD PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004325. PubMed ID: 26730709 [TBL] [Abstract][Full Text] [Related]
12. Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms. León G; Herrera M; Segura Á; Villalta M; Vargas M; Gutiérrez JM Toxicon; 2013 Dec; 76():63-76. PubMed ID: 24055551 [TBL] [Abstract][Full Text] [Related]
13. [Snake envenomation in French Guiana]. Chippaux JP Med Trop (Mars); 2002; 62(2):177-84. PubMed ID: 12192717 [TBL] [Abstract][Full Text] [Related]
14. Efficacy, safety, and use of snake antivenoms in the United States. Dart RC; McNally J Ann Emerg Med; 2001 Feb; 37(2):181-8. PubMed ID: 11174237 [TBL] [Abstract][Full Text] [Related]
15. Time for an alternative perspective: the eternal problem of supply and quality of anti snake venom in the developing world--"it's the economy, stupid". Simpson ID Wilderness Environ Med; 2008; 19(3):186-94. PubMed ID: 18715131 [TBL] [Abstract][Full Text] [Related]
16. Effects of snake envenomation: a guide for emergency nurses. McGhee S; Finnegan A; Clochesy JM; Visovsky C Emerg Nurse; 2015 Feb; 22(9):24-9. PubMed ID: 25659795 [TBL] [Abstract][Full Text] [Related]
17. Anti-human erythrocyte antibodies in horse-derived antivenoms used in the treatment of snakebite envenomations. León G; Rodríguez MA; Rucavado A; Lomonte B; Gutiérrez JM Biologicals; 2007 Mar; 35(1):5-11. PubMed ID: 16490363 [TBL] [Abstract][Full Text] [Related]
18. [Exotic snake bites in Switzerland]. Stadelmann M; Ionescu M; Chilcott M; Berney JL; Gétaz L Rev Med Suisse; 2010 May; 6(248):969-72. PubMed ID: 20545262 [TBL] [Abstract][Full Text] [Related]
19. Antivenoms for snakebite envenomings. Gutiérrez JM; León G; Lomonte B; Angulo Y Inflamm Allergy Drug Targets; 2011 Oct; 10(5):369-80. PubMed ID: 21745181 [TBL] [Abstract][Full Text] [Related]
20. Clinical studies of the effectiveness and safety of antivenoms. Williams DJ; Habib AG; Warrell DA Toxicon; 2018 Aug; 150():1-10. PubMed ID: 29746978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]